Nurexone Biologic Stock Current Valuation
| NRX Stock | 0.71 0.01 1.43% |
Valuation analysis of NurExone Biologic helps investors to measure NurExone Biologic's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Cash is likely to drop to about 514 K in 2024. Change In Cash is likely to climb to about (1.8 M) in 2024. Fundamental drivers impacting NurExone Biologic's valuation include:
Price Book 13.9433 | Enterprise Value 47 M | Enterprise Value Ebitda (7.24) |
Overvalued
Today
Please note that NurExone Biologic's price fluctuation is abnormally volatile at this time. Calculation of the real value of NurExone Biologic is based on 3 months time horizon. Increasing NurExone Biologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NurExone stock is determined by what a typical buyer is willing to pay for full or partial control of NurExone Biologic. Since NurExone Biologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NurExone Stock. However, NurExone Biologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.71 | Real 0.58 | Hype 0.71 | Naive 0.72 |
The intrinsic value of NurExone Biologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NurExone Biologic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NurExone Biologic helps investors to forecast how NurExone stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NurExone Biologic more accurately as focusing exclusively on NurExone Biologic's fundamentals will not take into account other important factors: NurExone Biologic Company Current Valuation Analysis
NurExone Biologic's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current NurExone Biologic Current Valuation | 46.99 M |
Most of NurExone Biologic's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NurExone Biologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, NurExone Biologic has a Current Valuation of 46.99 M. This is 99.67% lower than that of the Biotechnology sector and 98.99% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.72% higher than that of the company.
NurExone Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NurExone Biologic's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NurExone Biologic could also be used in its relative valuation, which is a method of valuing NurExone Biologic by comparing valuation metrics of similar companies.NurExone Biologic is currently under evaluation in current valuation category among its peers.
NurExone Fundamentals
| Return On Equity | -2.54 | ||||
| Return On Asset | -1.14 | ||||
| Current Valuation | 46.99 M | ||||
| Shares Outstanding | 70.84 M | ||||
| Shares Owned By Insiders | 4.75 % | ||||
| Number Of Shares Shorted | 32.31 K | ||||
| Price To Book | 13.94 X | ||||
| EBITDA | (4.09 M) | ||||
| Net Income | (3.64 M) | ||||
| Total Debt | 1.98 M | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (2.94 M) | ||||
| Short Ratio | 0.58 X | ||||
| Earnings Per Share | (0.11) X | ||||
| Target Price | 4.03 | ||||
| Beta | -0.091 | ||||
| Market Capitalization | 50.3 M | ||||
| Total Asset | 2.17 M | ||||
| Retained Earnings | (14.06 M) | ||||
| Working Capital | 74 K | ||||
| Net Asset | 2.17 M |
About NurExone Biologic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NurExone Biologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NurExone Biologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NurExone Biologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.